The Ras-MAPK pathway can also act as a tumor suppressor by inducing cell senescence and apoptosis, and as a MAPK subfamily, active ERK is abnormally elevated in breast cancer cells during development and progression (28), aberrant ERK activation leads to proliferation and apoptosis inhibition in breast cancer (29). This evidence concerns the gene MAPK1 and breast carcinoma.